Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

CUSIP: 23285D109

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+3,017,164
Put/Call ratio
5.3%
SEC-reported price per share
$10.21
Number of holders
100
Value change
+$29,671,547
Number of buys
63
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,063,934

Security key

23285D109

Report period

Q4 2022

Institutions

100

Top holders

10

Ownership snapshot

Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F 3/4/5 Lead comparable stake: 10% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 10%
HHLR ADVISORS, LTD. 6.8%
BlackRock Finance, Inc. 6.1%
VANGUARD GROUP INC 6%
BROWN CAPITAL MANAGEMENT LLC 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · Director, 10%+ Owner
10%
$196,969,000
13,381,054 shares
30 Sep 2022
HHLR ADVISORS, LTD.
13F
Company
13F
6.8%
$128,903,000
8,757,030 shares
30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
6.1%
$116,549,000
7,917,642 shares
30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
6%
$113,161,000
7,687,505 shares
30 Sep 2022
BROWN CAPITAL MANAGEMENT LLC
13F
Company
13F
3.4%
$64,863,000
4,406,461 shares
30 Sep 2022
Blue Water Life Science Advisors, LP
13F
Company
13F
1.6%
$30,912,000
2,100,000 shares
30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
100
Shares
64,201,674
Rows available
100
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
87
Q4 2022 holders
100
Holder diff
13
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .